What is Integrated Proteins Ltd. Quarterly Revenue?

Integrated Proteins Ltd. Quarterly Revenue Integrated Proteins Jun-2026 Quarterly Revenue is Rs 11 Cr which is growth of 22280.9% YoY.

What is Integrated Proteins Ltd. Quarterly Net Profit?

Integrated Proteins Ltd. Quarterly Net Profit Integrated Proteins Jun-2026 Quarterly Net Profit is Rs 0 Cr which is growth of 362500.0% YoY.

What is Integrated Proteins Ltd. Annual Revenue?

Integrated Proteins Ltd. Annual Revenue Integrated Proteins Mar-2026 Annual Revenue is Rs 10 Cr which is growth of -54.3% YoY.

What is Integrated Proteins Ltd. Annual Net Profit?

Integrated Proteins Ltd. Annual Net Profit Integrated Proteins Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of -10.0% YoY.

What is Integrated Proteins Ltd. Total Shareholders Fund?

Integrated Proteins Ltd. Total Shareholders Fund Integrated Proteins Mar-2025 Total Shareholders Fund is Rs 21 Cr which is growth of 2.0% YoY.

What is Integrated Proteins Ltd. Total Assets?

Integrated Proteins Ltd. Total Assets Integrated Proteins Mar-2025 Total Assets is Rs 21 Cr which is growth of -36.3% YoY.

What is Integrated Proteins Ltd. Book Value Per Share?

Integrated Proteins Ltd. Book Value Per Share Integrated Proteins Mar-2025 Book Value Per Share is 11 Rs which is growth of -81.1% YoY.

What is Integrated Proteins Ltd. ROE?

Integrated Proteins Ltd. ROE Integrated Proteins Mar-2025 ROE is 1% which is growth of 0.2% YoY.

What is Integrated Proteins Ltd. Cash From Operating Activity?

Integrated Proteins Ltd. Cash From Operating Activity Integrated Proteins Mar-2026 Cash From Operating Activity is Rs 4 Cr which is growth of 115.3% YoY.

What is Integrated Proteins Ltd. Net Cash Flow?

Integrated Proteins Ltd. Net Cash Flow Integrated Proteins Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -498.8% YoY.

Integrated Proteins Ltd.

BSE: 519606

Download real time

-0.27(-1.93%)

493.51% Gain from 52W Low

919

BSE Volume

BSE 09 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Integrated Proteins quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Integrated Proteins quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Integrated Proteins Jun-2026 Quarterly Revenue is Rs 11 Cr which is growth of 22280.9% YoY.
POSITIVE
Quarterly Net Profit Integrated Proteins Jun-2026 Quarterly Net Profit is Rs 0 Cr which is growth of 362500.0% YoY.

Integrated Proteins Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	10.6	5.7		4.2	0.1	21.5	0.1	0	0	0.4	0	0	0
SR_Q Operating Rev.	10.6	5.7		4.2		21.5	0			0.2
OI_Q Other Income	0				0.1	0	0.1	0	0	0.1	0	0	0
OEXPNS_Q Operating Exp.	10.1	5.5	0	4.1	0.1	21.3	0.1	0.1	0	0.3	0	0	0.1
OEXPNS_Q Operating Exp.	10.1	5.5	0	4.1	0.1	21.3	0.1	0.1	0	0.3	0	0	0.1
OP_Q Operating Profit	0.5	0.2	-0	0.1	-0.1	0.2	-0	-0.1	-0	-0.1	-0	-0	-0.1
OPMPCT_Q Operating Profit Margin %	4.44%	3.98%	-	2.10%	-	1.09%	-390.62%	-	-	-21.06%	-	-	-
DEP_Q Depr.											0	0	0
INT_Q Interest				0
PBT_Q Profit Before Tax	0.5	0.2	-0	0.1		0.3	0.1	-0		0.1	0	0	-0
TAX_Q Tax	0.1			0		0.1	0			0.1	-0.1	0	0
NP_Q Net Profit	0.4	0.2	-0	0.1		0.2	0.1	-0		0	0.1	0	-0
EPS_adj_Q EPS Adj. latest	0	0				0
NP_TTM Net profit TTM	0.6	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0	0
EPS_TTM Basic EPS TTM	0.3	0.1	0.8	1	0.7	0.7	0.2	0.2	0.3	0.3	0.3	0.1	0.1
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes			Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Integrated Proteins competitor comparison and performance snapshot within industry

Integrated Proteins revenue mix: sales, profit, and capital employed breakups by segment

Integrated Proteins annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Annual Revenue Integrated Proteins Mar-2026 Annual Revenue is Rs 10 Cr which is growth of -54.3% YoY.
NEGATIVE
Annual Net Profit Integrated Proteins Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of -10.0% YoY.

Integrated Proteins Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	220.8%	118.2%	20.5	9.9	21.7	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3
TotalOperatingRevenues_A Operating Rev. Ann.	267.2%	-	20.4	9.9	21.5	0.2	0.2							0.1
OI_A Other Income Ann.	0%	0%	0		0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
OEXPNS_A Operating Exp. Ann.	218.6%	149.7%	19.7	9.7	21.4	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1
OEXPNS_A Operating Exp. Ann.	218.6%	149.7%	19.7	9.7	21.4	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1
OP_A Operating Profit Ann.	-	-	0.8	0.3	0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1
OPMPCT_A OPM Ann. %	-	-		2.80%	0.42%	-24.39%	-26.46%	-49.74%	-63.99%	-71.24%	-81.12%	-47.58%	-44.76%	-24.76%
TotalExpenses_A Total Exp. Ann. ⌄	218.6%	149.7%		9.7	21.4	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.2
OtherExpenses_A Other Exp. Ann.	0%	0%	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
EmployeeBenefitExpenses_A Employee Exp. Ann.	-	-	0	0	0	0.1		0	0	0.1	0.1	0	0	0
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	44.2%	24.6%		0.3	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1
EBIDTPCT_A EBITDA Ann. margin %	-49.3%	-39.8%		2.85%	1.51%	26.79%	21.85%	50.26%	36.01%	28.76%	18.89%	52.43%	55.24%	43.81%
INT_A Interest Ann.	-	-	0
DEP_A Depr.	-	-			0	0	0	0	0	0	0	0	0	0
PBT_A PBT Ann.	-	-	0.8	0.3	0.3	0.1	0	0.1	0	0		0.1	0.1	0.1
TAX_A Tax Ann.	-	-	0.1	0.1	0.1	0	0	0	0	0	-0	0.1	0
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-	-		0.2	0.3	0.1	0	0	0	0	0	0	0.1	0.1
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-	-	0.6	0.2	0.3	0.1	0	0	0	0	0	0	0.1	0.1
NETPCT_A NPM Ann. %	-50.4%	-		2.26%	1.16%	37.61%	18.50%							102.39%
EPS_adj_A EPS Adj. latest Ann.	-	-		0	0
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

-54.4%

2Y CAGR

345%

3Y CAGR

220.8%

5Y CAGR

118.2%

7Y CAGR

74.6%

10Y CAGR

41.9%

Total Revenue Annual is falling faster than historical averages.

Net Profit Ann.

1Y CHG

-33.3%

2Y CAGR

41.4%

10Y CAGR

7.2%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

-54.7%

2Y CAGR

392.4%

3Y CAGR

218.6%

5Y CAGR

149.7%

7Y CAGR

92.2%

10Y CAGR

58%

Operating Expenses Annual Cr is falling faster than historical averages.

Integrated Proteins balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Integrated Proteins Mar-2025 Total Shareholders Fund is Rs 21 Cr which is growth of 2.0% YoY.
NEGATIVE
Total Assets Integrated Proteins Mar-2025 Total Assets is Rs 21 Cr which is growth of -36.3% YoY.

Integrated Proteins Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	101.7%	52.3%	20.5	20.1	2.6	2.5	2.5	2.5	2.4	2.4	2.5	2.5	2.5
EQCAP_A Equity Share Capital Ann.	75.7%	40.3%	19	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5
TotalShareCapital_A Total Share Capital Ann.	75.7%	40.3%	19	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-	-	1.5	-0.7	-0.9	-1	-1	-1.1	-1.1	-1.1	-1	-1	-1
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-	-	1.5	-0.7	-0.9	-1	-1	-1.1	-1.1	-1.1	-1	-1	-1
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-	-			0.1	0.2	0.1	0.1	0	0	0.1
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-			0	0	0	0	0	0	0.1
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-
CL_A Total Current Liabilities Ann. ⌄	0%	0%	0.1	12.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2
TradePayables_A Trade Payables Ann.	330.9%	-		8	0	0.1	0.1	0.1	0	0.1	0	0.2	0.2
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-	-	0.1	0.4	0.1	0	0	0	0			-0.1	0
ShortTermProvisions_A ST Provisions Ann.	-	-
TL_A Total Capital Plus Liabilities Ann.	94.5%	51.3%	20.6	32.4	2.7	2.8	2.7	2.6	2.6	2.6	2.6	2.6	2.7
FixedAssets_A Fixed Assets Ann. ⌄	-37%	-27.5%	0.1	0.1	0.4	0.4	0.4	0.5	0.5	0.5	0.6	0.6	0.6
TangibleAssets_A Tangible Assets Ann.	-37%	-27.5%	0.1	0.1	0.4	0.4	0.4	0.5	0.5	0.5	0.6	0.6	0.6
IntangibleAssets_A Intangible Assets Ann.	-	-
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-66.7%	-47%	0.1	0.1	2.6	2.7	2.6	2.4	2.3	2.2	2.1	2.1	2.1
NonCurrentInvestments_A Non Current Investments Ann.	-	-			0.2	0.1	0.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-			1.7	1.8	1.7	1.5	1.4	1.3	1.1	1.1	1.5
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	-		0	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4
CA_A Total Current Assets Ann. ⌄	490.6%	152.7%	20.6	32.3	0.1	0.1	0.1	0.2	0.3	0.4	0.6	0.5	0.5
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	-	-	2.1								0	0	0
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-	-	-0	0.1	0.1	0	0	0.2	0.2	0.3	0.4	0.5	0.5
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-
OtherCurrentAssets_A Other Current Assets Ann.	-	-	18.5	32.2	0	0	0	0	0	0	0.1
TA_A Total Assets Ann.	94.5%	51.3%	20.6	32.4	2.7	2.8	2.7	2.6	2.6	2.6	2.6	2.6	2.7
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	-
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	-		0.2	0.1	0.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-36.4%

2Y CAGR

176.2%

3Y CAGR

94.5%

5Y CAGR

51.3%

7Y CAGR

34.4%

10Y CAGR

22.5%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

-99.2%

10Y CAGR

-6.7%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

2Y CAGR

180.8%

3Y CAGR

101.7%

5Y CAGR

52.3%

7Y CAGR

35.9%

10Y CAGR

23.4%

Total ShareHolders Funds Annual growth is lower than historical averages.

Integrated Proteins ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Integrated Proteins Mar-2025 Book Value Per Share is 11 Rs which is growth of -81.1% YoY.
POSITIVE
ROE Integrated Proteins Mar-2025 ROE is 1% which is growth of 0.2% YoY.

Integrated Proteins Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	14.5%	9.1%	10.8	57.2	7.4	7.2	7.1	7	6.9	6.9	7.2	7.2	7.1
ROA_A RoA Ann. %	0%	6.1%	1.09%	0.77%	3.26%	1.09%	1.35%	0.81%	0.21%	0.96%	0.46%	1.84%	3.09%
ROE_A ROE Ann. %	-3.7%	4.9%	1.09%	1.24%	3.42%	1.22%	1.46%	0.86%	0.22%	1.02%	0.48%	1.88%	3.33%
ROCE_A ROCE Ann. %	-3.4%	4.1%	1.38%	1.58%	3.91%	1.53%	1.90%	1.13%	0.74%	0.15%	2.48%	3.31%	3.33%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-59.3%	-	2.85%	1.53%	54.88%	42.27%							139.41%
PBITMargin_A EBIT Ann. Margin %	-51.5%	-	2.85%	1.48%	43.76%	25.02%							102.39%
PBTMargin_A PBT Ann. Margin %	-51.5%	-	2.85%	1.48%	43.76%	25.02%							102.39%
NETPCT_A NPM Ann. %	-50.4%	-	2.26%	1.16%	37.61%	18.50%							102.39%
ASETTO_A Asset Turnover Ann. %	58.7%	-	0.4	1.2	0.1	0.1	-	-	-	-	-	-	0
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	573.3%	152.1%	244.2	2.6	1.2	0.8	0.7	2.4	3.1	3.7	12.9	7.9	2.8
QuickRatio_A Quick Ratio Ann.	573.3%	152.1%	244.2	2.6	1.2	0.8	0.7	2.4	3.1	3.7	12.9	7.9	2.8
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-
EarningRetention_A Earning Retention Ann. %	-	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	215.7%	168.1%	138.5	17.8	5.7	4.4	5.3	1	0.7	0.5	0.3	0.3	0.3
EVPerNetSales_A EV Per Net Sales Ann.	-19%	-	13.9	0.8	23.9	26.2							3.1
PBV_A Price To Book Value Adjusted	-15.4%	-10.1%	1.27	0.22	2.03	2.1	2.13	2.16	2.18	2.19	2.09	1.82	1.86
EVPerEBITDA_A EV Per EBITDA Ann.	99%	94.8%	488.7	54	43.6	62	68.1	17.4	13.8	16.2	3.7	2.8	2.3
MarketCapPerSales_A Market Cap Per Sales Ann.	-18%	-	13.9	0.7	24	25.2							9.3
RetentionRatios_A Retention Ratio Ann. %	-	-	-
EYield_A Earnings Yield Ann.	-	-		0	0	0	0	0	0	0	0	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.				0.2	0	0.1	0	0

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-12.1%

2Y CAGR

-43.5%

3Y CAGR

-3.7%

5Y CAGR

4.9%

7Y CAGR

10Y CAGR

-10.6%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

41.6%

2Y CAGR

-42.2%

5Y CAGR

6.1%

7Y CAGR

1.8%

10Y CAGR

-9.9%

RoA Annual % is growing faster than historical averages.

Current Ratio Ann.

1Y CHG

9292.3%

2Y CAGR

1326.5%

3Y CAGR

573.3%

5Y CAGR

152.1%

7Y CAGR

81.9%

10Y CAGR

56.3%

Current Ratio Annual growth is higher than historical averages.

Integrated Proteins cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Integrated Proteins Mar-2026 Cash From Operating Activity is Rs 4 Cr which is growth of 115.3% YoY.
NEGATIVE
Net Cash Flow Integrated Proteins Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -498.8% YoY.

Integrated Proteins Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	-	-	3.6	-23.6	-0.1	-0.1	-0.1	-0.1	-0.2	0.1	-0.2	-0.2	-0.1
PBT_A PBT Ann.	-	-	0.3	0.3	0.1	0	0.1	0	0		0.1	0.1	0.1
INT_A Interest Ann.	-	-
TAX_A Tax Ann.	-	-	0.1	0.1	0	0	0	0	0	-0	0.1	0
CFI_A Cash from Investing Act. Ann.	-	-		2.5	0.2		0	0	0	0	0.2	0.2	0.2
CFA_A Cash from Financing Act. Ann.	-	-	-3.7	21.1	-0.2	0.1	0.1	0		-0.1
NCF_A Net Cash Flow Ann. ⌄	-	-	-0.1	0	-0.1	-0	-0	-0	-0.1	0.1	-0.1	-0	0.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	0%	-12.9%	0.1	0.1	0.1	0.1	0.2	0.2	0.3		0.5	0.5	0.4
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-	-	-0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.4	0.5	0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

7Y CAGR

66.9%

Cash from Operating Activity Annual growth is stable compared to historical averages.

Cash from Investing Act. Ann.

1Y CHG

1150%

7Y CAGR

43.5%

Integrated Proteins investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents

493.51% Gain from 52W Low

Integrated Proteins quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents